WallStreetZenWallStreetZen

NYSE: LLY
Eli Lilly & Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LLY

Based on 16 analysts offering 12 month price targets for Eli Lilly & Co.
Min Forecast
$313.00-8.51%
Avg Forecast
$384.19+12.3%
Max Forecast
$440.00+28.62%

Should I buy or sell LLY stock?

Based on 16 analysts offering ratings for Eli Lilly & Co.
Strong Buy
Strong Buy
9 analysts 56.25%
Buy
5 analysts 31.25%
Hold
2 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LLY stock forecasts and price targets.

LLY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barclays
Bottom 6%
6
Strong BuyMaintains$400.00+16.92%2023-01-03
SVB Leerink
Top 7%
94
BuyMaintains$410.00+19.85%2022-12-16
UBS
Bottom 2%
2
Strong BuyMaintains$420.00+22.77%2022-12-15
Morgan Stanley
Top 25%
76
Strong BuyMaintains$440.00+28.62%2022-12-14
Wells Fargo
Top 12%
89
HoldMaintains$375.00+9.62%2022-12-08
Guggenheim
Bottom 14%
14
Strong BuyMaintains$401.00+17.22%2022-12-07
Credit Suisse
Bottom 20%
20
BuyMaintains$400.00+16.92%2022-12-06
Cowen & Co.
Top 29%
72
BuyMaintains$430.00+25.69%2022-12-05
Berenberg
Top 37%
64
Strong BuyMaintains$375.00+9.62%2022-11-22
Goldman Sachs
Top 12%
89
HoldMaintains$313.00-8.51%2022-11-08

1 of 2

Forecast return on equity

Is LLY forecast to generate an efficient return?
Company
N/A
Industry
7.08%
Market
12.46%

Forecast return on assets

Is LLY forecast to generate an efficient return on assets?
Company
N/A
Industry
3.01%

LLY earnings per share forecast

What is LLY's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$9.33+39.67%
Avg 2 year Forecast
$12.82+91.92%
Avg 3 year Forecast
$17.03+154.94%
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

LLY revenue forecast

What is LLY's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$30.8B+5.24%
Avg 2 year Forecast
$35.6B+21.84%
Avg 3 year Forecast
$41.0B+40.38%
LLY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LLY earnings growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
35.92%
Industry
24.26%
Market
24.23%
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
LLY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

LLY revenue growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
11.8%
Industry
2.73%
Market
9.31%
LLY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LLY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LLY vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
LLY$342.10$384.19+12.30%Strong Buy
MRK$105.38$112.87+7.10%Strong Buy
ABBV$146.28$165.25+12.97%Buy
PFE$43.79$53.50+22.17%Hold
JNJ$168.23$181.82+8.08%Buy
View Top General Drug Manufacturer Stocks

Eli Lilly & Co Stock Forecast FAQ

Is Eli Lilly & Co Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 16 Wall Street analysts covering (NYSE: LLY) stock is to Strong Buy LLY stock.

Out of 16 analysts, 9 (56.25%) are recommending LLY as a Strong Buy, 5 (31.25%) are recommending LLY as a Buy, 2 (12.5%) are recommending LLY as a Hold, 0 (0%) are recommending LLY as a Sell, and 0 (0%) are recommending LLY as a Strong Sell.

If you're new to stock investing, here's how to buy Eli Lilly & Co stock.

What is LLY's earnings growth forecast for 2023-2025?

(NYSE: LLY) Eli Lilly & Co's forecast annual earnings growth rate of 35.92% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 24.26%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 24.23%.

Eli Lilly & Co's earnings in 2023 is $6,033,200,000.On average, 9 Wall Street analysts forecast LLY's earnings for 2023 to be $8,865,159,807, with the lowest LLY earnings forecast at $7,924,483,686, and the highest LLY earnings forecast at $9,311,743,420. On average, 5 Wall Street analysts forecast LLY's earnings for 2024 to be $12,181,280,678, with the lowest LLY earnings forecast at $11,953,237,982, and the highest LLY earnings forecast at $12,618,362,512.

In 2025, LLY is forecast to generate $16,181,529,637 in earnings, with the lowest earnings forecast at $15,867,970,930 and the highest earnings forecast at $16,485,586,565.

What is LLY's revenue growth forecast for 2023-2025?

(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 11.8% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 2.73%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.31%.

Eli Lilly & Co's revenue in 2023 is $29,239,500,000.On average, 5 Wall Street analysts forecast LLY's revenue for 2023 to be $29,238,640,595,037, with the lowest LLY revenue forecast at $28,476,831,663,000, and the highest LLY revenue forecast at $29,864,957,009,067. On average, 5 Wall Street analysts forecast LLY's revenue for 2024 to be $33,850,259,669,700, with the lowest LLY revenue forecast at $32,908,461,388,600, and the highest LLY revenue forecast at $34,508,256,915,272.

In 2025, LLY is forecast to generate $39,002,427,350,250 in revenue, with the lowest revenue forecast at $38,106,884,679,500 and the highest revenue forecast at $39,897,970,021,000.

What is LLY's forecast return on assets (ROA) for 2023-2026?

(NYSE: LLY) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 3.01%.

What is LLY's Price Target?

According to 16 Wall Street analysts that have issued a 1 year LLY price target, the average LLY price target is $384.19, with the highest LLY stock price forecast at $440.00 and the lowest LLY stock price forecast at $313.00.

On average, Wall Street analysts predict that Eli Lilly & Co's share price could reach $384.19 by Jan 3, 2024. The average Eli Lilly & Co stock price prediction forecasts a potential upside of 12.3% from the current LLY share price of $342.10.

What is LLY's Earnings Per Share (EPS) forecast for 2023-2025?

(NYSE: LLY) Eli Lilly & Co's current Earnings Per Share (EPS) is $6.68. On average, analysts forecast that LLY's EPS will be $9.33 for 2023, with the lowest EPS forecast at $8.34, and the highest EPS forecast at $9.80. On average, analysts forecast that LLY's EPS will be $12.82 for 2024, with the lowest EPS forecast at $12.58, and the highest EPS forecast at $13.28. In 2025, LLY's EPS is forecast to hit $17.03 (min: $16.70, max: $17.35).

What is LLY's forecast return on equity (ROE) for 2023-2026?

(NYSE: LLY) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.